Cargando…
The Association Between HbA(1c) and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
OBJECTIVE: According to recent guidelines, individuals with type 1 diabetes should spend <4.0% of time per day with glucose levels <3.9 mmol/L (<70 mg/dL) and <1.0% per day with glucose levels <3.0 mmol/L (<54 mg/dL). RESEARCH DESIGN AND METHODS: In the GOLD randomized crossover tr...
Autores principales: | Seyed Ahmadi, Shilan, Westman, Klara, Pivodic, Aldina, Ólafsdóttir, Arndís F., Dahlqvist, Sofia, Hirsch, Irl B., Hellman, Jarl, Ekelund, Magnus, Heise, Tim, Polonsky, William, Wijkman, Magnus, Schwarcz, Erik, Lind, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440892/ https://www.ncbi.nlm.nih.gov/pubmed/32641374 http://dx.doi.org/10.2337/dc19-2606 |
Ejemplares similares
-
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
por: Ólafsdóttir, Arndís F., et al.
Publicado: (2018) -
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)
por: Ólafsdóttir, Arndís F., et al.
Publicado: (2020) -
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
por: Sofizadeh, Sheyda, et al.
Publicado: (2019) -
HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
por: Lind, Marcus, et al.
Publicado: (2019) -
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry
por: Hallström, Sara, et al.
Publicado: (2021)